Repligen and Novasign have joined forces in a strategic partnership aimed at integrating Novasign’s machine learning and modeling workflow into Repligen’s filtration systems. The collaboration seeks to enhance Repligen’s digitalization journey by incorporating Novasign’s expertise in bioprocessing, AI, machine learning, modeling, and software engineering. This strategic move not only aims to scale and expand Novasign’s operations but also to revolutionize process development in bioprocessing.
The integration of Novasign’s modeling workflow into Repligen’s tangential flow filtration (TFF) systems is a significant step towards bolstering Repligen’s portfolio of process analytical technology (PAT)-enabled systems. By incorporating advanced AI modeling capabilities, the partnership endeavors to streamline process development, enable real-time predictive control, and reduce development timelines and costs through the deployment of digital twins. This innovative approach is poised to transform how bioprocessing systems operate and evolve.
Novasign’s specialization in bioprocessing, modeling, and software engineering brings a wealth of AI-powered solutions to the table, covering cultivation, harvest, filtration, and chromatography processes. The company’s multi-use models leverage experimental data to extract actionable insights applicable to various modalities, products, and scales. This approach promises smarter process development, improved monitoring and control, and a substantial reduction in time, cost, and risk associated with bioprocessing operations.
The collaborative efforts between Repligen and Novasign aim to integrate automated manufacturing systems with smart sensors and digital twins capabilities. By doing so, they intend to expedite process development and ensure a more efficient and reliable scale-up for customers. The fusion of intelligent modeling workflows, PAT, and smart devices is expected to drive down development costs significantly while enhancing process understanding within the bioprocessing industry. This partnership underscores Novasign’s commitment to innovation and its pivotal role in advancing bioprocess digitalization for the long term.
Key Takeaways:
– The partnership between Repligen and Novasign aims to integrate advanced AI modeling and digital twins capabilities into bioprocessing systems to streamline process development.
– Novasign’s expertise in bioprocessing, AI, machine learning, and software engineering promises smarter process development and reduced time, cost, and risk in bioprocessing operations.
– The collaboration between Repligen and Novasign signifies a strong commitment to revolutionizing bioprocessing through innovation and advanced technology.
– By combining automated manufacturing systems with smart sensors and digital twins, the partnership seeks to accelerate process development and enhance efficiency in bioprocessing scale-up.
Tags: process development, filtration, biotech, digital twins, bioprocess, chromatography, process analytical technology
Read more on genengnews.com